Welcome to Justin Stindt Consultants, your dedicated market access consulting partner for Business Development & Licensing services. As a leading market access consultancy in the pharmaceutical , biotech , and medtech industries, we help companies expand their reach through strategic partnerships and licensing agreements. Our expertise is rooted in deep market knowledge of the EU5 and the USA so we can pinpoint potential distributors and development partners in each country. Leveraging our consultancy’s global network and personalized approach, we connect you with contacts who are the best fit to bring your products to new markets, integrating business development with market access insights.
Strategic Business Development & Licensing (BD&L) for Life Sciences
In the Pharma, Biotech, and Medtech sectors, a successful licensing or partnership deal depends on a realistic valuation and a clear path to reimbursement. Justin Stindt Consultants integrates deep Market Access insights into the BD&L process, helping companies navigate In-licensing and Out-licensing opportunities in the EU5 and US markets.
- In-licensing Support: We de-risk acquisitions by conducting commercial due diligence, forecasting “Gross-to-Net” dynamics, and validating pricing assumptions to ensure a high ROI.
- Out-licensing Excellence: We build compelling value propositions backed by payer and prescriber feedback, ensuring you attract the right partners without “leaving money on the table.”
- Global Partner Mapping: Leveraging an extensive industry network, we identify and vet distributors and strategic partners tailored to your product’s therapeutic fit and geographic goals.
The JSC Advantage: Unlike traditional BD firms, we analyze the competitive landscape and payer environment simultaneously, ensuring your partner can actually secure market uptake and reimbursement.
Developing Business Development & Licensing Strategies For Pharma, Biotech And Medtech
Strategic partnerships and licensing deals are essential for expanding market access. Our consultancy designs comprehensive business development strategies that align with your product’s value and target markets. As part of our agency’s Business Development & Licensing support, we start by understanding your company’s specific objectives: whether you are looking to in-license to strengthen your pipeline or looking to out-license to find the right partner to bring your product to the market and/or finance your further development, we have got you covered. Our market access consulting firm has a successful track record of preparing the right materials to attract partners, supporting the negotiation of terms sheets and final offers and the integration of the asset.
In-licensing deals
For In-licensing deals, our strategy consultancy supports clients with screening for the right targets, analyzing non-confidential pitch decks and confidential information once a confidentiality agreement is signed and commercial due diligence once a term sheet / non-binding offer has been agreed. Key components of this include thorough analysis of epidemiological data to ensure your company knows the correct market size, forecasting of achievable market shares and Market Access / Pricing & Reimbursement. In our BD&L consulting firm’s experience some of the most common pitfalls include overestimation of the achievable Pricing & Reimbursement before overestimation of market shares and underestimation of competitive risks. We frequently see other vendors ignoring gross to net dynamics in the US and EU or projecting EU prices as a mere extrapolation from US prices which can lead to expensive miscalculations of the opportunity. In contrast to this our consultancy forecasts specifically US gross to net and list price and net prices in major EU markets. Knowing what the asset is really worth enables you to pay a fair price and ensure your return on investment.
Out-licensing deals
For Out-licensing deals, our consulting firm support our clients with presenting credible and attractive value propositions to potential partners. This includes realistic and credible assumptions on market size and pricing based on thorough secondary research and substantiated by payer and prescriber customer feedback. Our market access consulting agency analyzes market needs, competitive landscapes, and payer environments in each country to prioritize where your product can deliver the most value. Then we identify potential Out-licensing or distribution partners who have the right geographic coverage and expertise. By considering factors like local payer requirements and regulatory pathways, we ensure the partners we target are well-equipped to navigate pricing and reimbursement challenges alongside you. In practice, this means looking at each target country’s dynamics, for example, focusing on EU5 and US specialists when those are your launch markets, while remaining open to partners in other European territories. Knowing the market and pricing potential of your asset helps you to attract strategic partners and not to leave any money on the table in the negotiations.
As a reputable Business Development & Licensing strategy advisor we strongly believe that BD&L deals create win-win opportunities for both partners and we help set up these partnerships for sustainable success.
ROBUST PARTNERSHIP STRATEGIES BASED ON DEEP MARKET INSIGHTS
In our experience, successful licensing and distribution strategies rely on a deep understanding of both your product and the partner’s profile. We employ a rigorous, bespoke methodology: mapping potential partner organizations , conducting stakeholder interviews, and evaluating each candidate’s commercial track record and network. By integrating market access research (including payer interviews and pricing benchmarks ) into our partner search, we make sure that the companies we introduce can secure reimbursement and market uptake for your product. In the same way, we tailor every business development strategy to your specific situation. Our consultants combine their background in business development and licensing with market access expertise, enabling them to navigate complex market landscapes and find the ideal partner profile.
Business Development & Licensing - What Sets Justin Stindt Consultants Apart?
- Extensive international experience: We serve leading pharmaceutical, biotech, and medtech clients across Europe and the United States. Our focus on the EU5 markets (France, Germany, Italy, Spain, UK) and the US, while remaining active in other regions, means we understand local market nuances for each geography.
- Market sizing substantiated by payer and prescriber customer feedback and secondary research: As a strategic Market Access consulting firm we leverage best available insights on epi, market shares and achievable Pricing & Reimbursement by triangulating secondary research, payer and prescriber interviews and our company’s experience from hundreds of projects
- Customized partner matching: Every product and market is unique. We craft a tailored partner search for you, considering therapeutic fit, market coverage, and your strategic goals. This bespoke approach ensures that recommended distributors or licensing partners truly match your needs.
- Integrated market access perspective: Unlike pure business development firms, we bring market access insight into the process. We assess payer preferences , reimbursement pathways , and competitive positioning so that any partner we introduce can effectively navigate market access hurdles for your product.
- Proven track record: We have already connected multiple clients with distributors and licensees that proved to be an excellent fit for their products. Our experience working with startups, biotechs, and large pharma alike helps your project benefit from best practices and lessons learned across many successful launches.
- Strong industry network: Our consultants have built relationships with a wide range of industry contacts, from local specialty distributors to global pharma companies. This network gives you access to decision-makers who are often inaccessible on your own, increasing the chances of finding the right partner quickly.
FAQ
1. What are common pitfalls in Life Science In-licensing deals?
The most frequent mistakes include overestimating achievable pricing and reimbursement and ignoring the complex Gross-to-Net dynamics in the US and EU markets. Many firms also fail to account for future competitive risks or simply extrapolate EU prices from US benchmarks, leading to significant overvaluation of the asset. Each of these mistakes is avoidable, but only if addressed before the deal is structured.
2. How does Market Access expertise improve Out-licensing outcomes?
By integrating Market Access early, you can present a credible and substantiated value proposition to potential partners. Providing data-backed assumptions on pricing, based on actual payer and prescriber feedback, increases the asset’s attractiveness and strengthens your position during term sheet negotiations.
3. Why focus on the EU5 and US markets for licensing partnerships?
The US and EU5 (Germany, France, Italy, Spain, UK) represent the highest value markets but also the most complex regulatory and reimbursement environments. A partner with specific expertise in these geographies is essential to navigate local nuances, ensuring that the product doesn’t just launch, but successfully secures funding and patient access.
4. How do you identify the "right fit" partner for Medtech distribution?
A “right fit” partner is evaluated beyond their sales reach. We analyze their commercial track record, their existing network with local payers and clinicians, and their ability to handle region-specific reimbursement challenges (like DRG codes or specialized funding pathways).
Connect with our team
Get in touch with our expert
CLIENT TESTIMONIALS
